Selected research
Market Analysis & Forecast
Global Taxifolin Market Analysis and Forecast 2026-2032
Market perspective
The global Taxifolin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Taxifolin's global sales reached XX (KG) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Ametis JSC as the global sales leader, a title it has maintained for several consecutive years. Notably, Ametis JSC's performance in primary markets is also remarkable. In the Chinese market, sales were XX (KG), a change of XX% from the previous year. In Europe, sales were XX (KG), showing a year-on-year of XX%. In the US, sales were XX (KG), a year-on-year change of XX%.
The major global manufacturers in the Taxifolin market include Ametis JSC, JW Health Products, Kalenika Group, Hefei Lifeon Pharma, ROBIOS, Kingherbs Ltd, Beton Nutrition Corporation and Xi'an Sost Biotech Co.,Ltd, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the Taxifolin production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of Taxifolin by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for Taxifolin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Taxifolin, also provides the consumption of main regions and countries. Of the upcoming market potential for Taxifolin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Taxifolin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Taxifolin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Taxifolin sales, projected growth trends, production technology, application and end-user industry.
Taxifolin Segment by Company
Ametis JSC
JW Health Products
Kalenika Group
Hefei Lifeon Pharma
ROBIOS
Kingherbs Ltd
Beton Nutrition Corporation
Xi'an Sost Biotech Co.,Ltd
Taxifolin Segment by Type
Below 92%
92%-98%
Above 98%
Taxifolin Segment by Application
Food and Beverages
Healthcare
Cosmetics
Agriculture
Others
Taxifolin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taxifolin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taxifolin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taxifolin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Taxifolin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Taxifolin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Taxifolin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Taxifolin sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 92%
- 92%-98%
- Above 98%
Applications
- Food and Beverages
- Healthcare
- Cosmetics
- Agriculture
- Others
Companies covered
- Ametis JSC
- JW Health Products
- Kalenika Group
- Hefei Lifeon Pharma
- ROBIOS
- Kingherbs Ltd
- Beton Nutrition Corporation
- Xi'an Sost Biotech Co.,Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Taxifolin Market by Type
- 1.2.1 Global Taxifolin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Below 92%
- 1.2.3 92%-98%
- 1.2.4 Above 98%
- 1.3 Taxifolin Market by Application
- 1.3.1 Global Taxifolin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Food and Beverages
- 1.3.3 Healthcare
- 1.3.4 Cosmetics
- 1.3.5 Agriculture
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Taxifolin Market Dynamics
- 2.1 Taxifolin Industry Trends
- 2.2 Taxifolin Industry Drivers
- 2.3 Taxifolin Industry Opportunities and Challenges
- 2.4 Taxifolin Industry Restraints
3 Global Taxifolin Production Overview
- 3.1 Global Taxifolin Production Capacity (2021-2032)
- 3.2 Global Taxifolin Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Taxifolin Production by Region
- 3.3.1 Global Taxifolin Production by Region (2021-2026)
- 3.3.2 Global Taxifolin Production by Region (2027-2032)
- 3.3.3 Global Taxifolin Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Taxifolin Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Taxifolin Revenue by Region
- 4.2.1 Global Taxifolin Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Taxifolin Revenue by Region (2021-2026)
- 4.2.3 Global Taxifolin Revenue by Region (2027-2032)
- 4.2.4 Global Taxifolin Revenue Market Share by Region (2021-2032)
- 4.3 Global Taxifolin Sales Estimates and Forecasts 2021-2032
- 4.4 Global Taxifolin Sales by Region
- 4.4.1 Global Taxifolin Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Taxifolin Sales by Region (2021-2026)
- 4.4.3 Global Taxifolin Sales by Region (2027-2032)
- 4.4.4 Global Taxifolin Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Taxifolin Revenue by Manufacturers
- 5.1.1 Global Taxifolin Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Taxifolin Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Taxifolin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Taxifolin Sales by Manufacturers
- 5.2.1 Global Taxifolin Sales by Manufacturers (2021-2026)
- 5.2.2 Global Taxifolin Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Taxifolin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Taxifolin Sales Price by Manufacturers (2021-2026)
- 5.4 Global Taxifolin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Taxifolin Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Taxifolin Manufacturers, Product Type & Application
- 5.7 Global Taxifolin Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Taxifolin Market CR5 and HHI
- 5.8.2 2025 Taxifolin Tier 1, Tier 2, and Tier 3
6 Taxifolin Market by Type
- 6.1 Global Taxifolin Revenue by Type
- 6.1.1 Global Taxifolin Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Taxifolin Revenue Market Share by Type (2021-2032)
- 6.2 Global Taxifolin Sales by Type
- 6.2.1 Global Taxifolin Sales by Type (2021-2032) & (KG)
- 6.2.2 Global Taxifolin Sales Market Share by Type (2021-2032)
- 6.3 Global Taxifolin Price by Type
7 Taxifolin Market by Application
- 7.1 Global Taxifolin Revenue by Application
- 7.1.1 Global Taxifolin Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Taxifolin Revenue Market Share by Application (2021-2032)
- 7.2 Global Taxifolin Sales by Application
- 7.2.1 Global Taxifolin Sales by Application (2021-2032) & (KG)
- 7.2.2 Global Taxifolin Sales Market Share by Application (2021-2032)
- 7.3 Global Taxifolin Price by Application
8 Company Profiles
- 8.1 Ametis JSC
- 8.1.1 Ametis JSC Company Information
- 8.1.2 Ametis JSC Business Overview
- 8.1.3 Ametis JSC Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Ametis JSC Taxifolin Product Portfolio
- 8.1.5 Ametis JSC Recent Developments
- 8.2 JW Health Products
- 8.2.1 JW Health Products Company Information
- 8.2.2 JW Health Products Business Overview
- 8.2.3 JW Health Products Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 JW Health Products Taxifolin Product Portfolio
- 8.2.5 JW Health Products Recent Developments
- 8.3 Kalenika Group
- 8.3.1 Kalenika Group Company Information
- 8.3.2 Kalenika Group Business Overview
- 8.3.3 Kalenika Group Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Kalenika Group Taxifolin Product Portfolio
- 8.3.5 Kalenika Group Recent Developments
- 8.4 Hefei Lifeon Pharma
- 8.4.1 Hefei Lifeon Pharma Company Information
- 8.4.2 Hefei Lifeon Pharma Business Overview
- 8.4.3 Hefei Lifeon Pharma Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Hefei Lifeon Pharma Taxifolin Product Portfolio
- 8.4.5 Hefei Lifeon Pharma Recent Developments
- 8.5 ROBIOS
- 8.5.1 ROBIOS Company Information
- 8.5.2 ROBIOS Business Overview
- 8.5.3 ROBIOS Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 ROBIOS Taxifolin Product Portfolio
- 8.5.5 ROBIOS Recent Developments
- 8.6 Kingherbs Ltd
- 8.6.1 Kingherbs Ltd Company Information
- 8.6.2 Kingherbs Ltd Business Overview
- 8.6.3 Kingherbs Ltd Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Kingherbs Ltd Taxifolin Product Portfolio
- 8.6.5 Kingherbs Ltd Recent Developments
- 8.7 Beton Nutrition Corporation
- 8.7.1 Beton Nutrition Corporation Company Information
- 8.7.2 Beton Nutrition Corporation Business Overview
- 8.7.3 Beton Nutrition Corporation Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Beton Nutrition Corporation Taxifolin Product Portfolio
- 8.7.5 Beton Nutrition Corporation Recent Developments
- 8.8 Xi'an Sost Biotech Co.,Ltd
- 8.8.1 Xi'an Sost Biotech Co.,Ltd Company Information
- 8.8.2 Xi'an Sost Biotech Co.,Ltd Business Overview
- 8.8.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.8.4 Xi'an Sost Biotech Co.,Ltd Taxifolin Product Portfolio
- 8.8.5 Xi'an Sost Biotech Co.,Ltd Recent Developments
9 North America
- 9.1 North America Taxifolin Market Size by Type
- 9.1.1 North America Taxifolin Revenue by Type (2021-2032)
- 9.1.2 North America Taxifolin Sales by Type (2021-2032)
- 9.1.3 North America Taxifolin Price by Type (2021-2032)
- 9.2 North America Taxifolin Market Size by Application
- 9.2.1 North America Taxifolin Revenue by Application (2021-2032)
- 9.2.2 North America Taxifolin Sales by Application (2021-2032)
- 9.2.3 North America Taxifolin Price by Application (2021-2032)
- 9.3 North America Taxifolin Market Size by Country
- 9.3.1 North America Taxifolin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Taxifolin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Taxifolin Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Taxifolin Market Size by Type
- 10.1.1 Europe Taxifolin Revenue by Type (2021-2032)
- 10.1.2 Europe Taxifolin Sales by Type (2021-2032)
- 10.1.3 Europe Taxifolin Price by Type (2021-2032)
- 10.2 Europe Taxifolin Market Size by Application
- 10.2.1 Europe Taxifolin Revenue by Application (2021-2032)
- 10.2.2 Europe Taxifolin Sales by Application (2021-2032)
- 10.2.3 Europe Taxifolin Price by Application (2021-2032)
- 10.3 Europe Taxifolin Market Size by Country
- 10.3.1 Europe Taxifolin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Taxifolin Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Taxifolin Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Taxifolin Market Size by Type
- 11.1.1 China Taxifolin Revenue by Type (2021-2032)
- 11.1.2 China Taxifolin Sales by Type (2021-2032)
- 11.1.3 China Taxifolin Price by Type (2021-2032)
- 11.2 China Taxifolin Market Size by Application
- 11.2.1 China Taxifolin Revenue by Application (2021-2032)
- 11.2.2 China Taxifolin Sales by Application (2021-2032)
- 11.2.3 China Taxifolin Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Taxifolin Market Size by Type
- 12.1.1 Asia Taxifolin Revenue by Type (2021-2032)
- 12.1.2 Asia Taxifolin Sales by Type (2021-2032)
- 12.1.3 Asia Taxifolin Price by Type (2021-2032)
- 12.2 Asia Taxifolin Market Size by Application
- 12.2.1 Asia Taxifolin Revenue by Application (2021-2032)
- 12.2.2 Asia Taxifolin Sales by Application (2021-2032)
- 12.2.3 Asia Taxifolin Price by Application (2021-2032)
- 12.3 Asia Taxifolin Market Size by Country
- 12.3.1 Asia Taxifolin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Taxifolin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Taxifolin Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Taxifolin Market Size by Type
- 13.1.1 SAMEA Taxifolin Revenue by Type (2021-2032)
- 13.1.2 SAMEA Taxifolin Sales by Type (2021-2032)
- 13.1.3 SAMEA Taxifolin Price by Type (2021-2032)
- 13.2 SAMEA Taxifolin Market Size by Application
- 13.2.1 SAMEA Taxifolin Revenue by Application (2021-2032)
- 13.2.2 SAMEA Taxifolin Sales by Application (2021-2032)
- 13.2.3 SAMEA Taxifolin Price by Application (2021-2032)
- 13.3 SAMEA Taxifolin Market Size by Country
- 13.3.1 SAMEA Taxifolin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Taxifolin Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Taxifolin Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Taxifolin Value Chain Analysis
- 14.1.1 Taxifolin Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Taxifolin Production Mode & Process
- 14.2 Taxifolin Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Taxifolin Distributors
- 14.2.3 Taxifolin Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst